Summit Therapeutics (SMMT) null Earnings

17MarConfirmed
Aug 21
Q2 2021
Nov 21
Mar 22
-1.35
-0.96
-0.57
-0.18

Details

Expected EPS
-0.27
Actual EPS
-0.28
Surprise EPS
-0.01
Surprise Percent
+3.7%

Description

Summit Therapeutics (SMMT) has reported earnings of -0.28 per share for .

0 Comments

Share your thoughts